Dr. Zu-Chian Chiang | Biological macromolecules | Best Researcher Award |

Postdoctoral Fellow, at Fujian Normal University ,China

Dr. Zu-Chian Chiang (蔣祖搴), Ph.D., is a dedicated postdoctoral researcher currently working at the Biomedical Research Center of Southern China, Fujian Normal University, Qishan Campus, Fuzhou, China. With a strong academic and research foundation rooted in Taiwan, Dr. Chiang has developed expertise in biomedical sciences, materials chemistry, and clinical applications of advanced therapeutic technologies. He has worked with prestigious institutions such as Academia Sinica and National Taiwan University Hospital, contributing significantly to translational medicine, particularly in targeted cancer therapy and regenerative medicine. His collaborative and cross-disciplinary approach reflects a deep commitment to scientific advancement and public health.

Professional Profile

Scopus

Education 🎓

Dr. Chiang earned his Ph.D. in Materials and Chemical Engineering from the College of Engineering and Science at National United University, Taiwan (2008–2014), where he also served as a teaching assistant across various chemistry and engineering courses. He completed his M.S. in Chemistry at Tunghai University, Taiwan (2005–2007), laying the foundation for his specialization in organic chemistry and material science. His academic path has been enriched by mentorship from notable scholars such as Prof. An-Chong Chao and Prof. Feng-Di Lung.

Experience 👩‍

Dr. Chiang has over a decade of research experience across Taiwan and China. His postdoctoral journey began at the Clinical Trial Center of National Taiwan University Hospital, followed by appointments at Academia Sinica’s Institute of Biological Chemistry under the Taiwan Protein Project and Translational Innovation programs. Since 2019, he has been a postdoctoral fellow at Fujian Normal University, collaborating with Prof. Qi Chen. He also brings a strong teaching background, having served as a teaching and lab assistant in various chemistry and engineering courses during his graduate studies.

Research Interests 🔬

Dr. Chiang’s research centers on the development of functional peptides and biopolymeric complexes for cancer research and bone tissue engineering. He specializes in cutting-edge areas such as Antibody-Drug Conjugates (ADCs) for targeted cancer therapy, specific aptamers used as molecular agonists or antagonists, and the synthesis of multifunctional biomaterials for regenerative medicine. His interdisciplinary work bridges the gap between chemical engineering and biomedical applications, aiming to design smarter and more effective therapeutic strategies.

Awards 🏆

Dr. Chiang has been recognized for his excellence with several prestigious awards, including the 2020 Science and Technology Commissioner of Quanzhou (Fujian Province) and the 3rd Biotech Elite Training Reserve Program Award by the Executive Yuan, Taiwan. Other accolades include the Chung Hwa Rotary Doctoral Program Award (2012), the Outstanding Doctoral Scholarship at National United University (2010), and the Master’s Program Scholarship from the Hunan Fellow Association (2007). His leadership is also recognized by Rotary International through various honors and leadership roles.

Top Noted Publications 📚

Dr. Chiang has authored and co-authored several impactful publications in international journals. His recent works include:

Development of 7DC-DM1, a CD47-targeting ADC with anti-tumor effects (IJ Biological Macromolecules, 2025).

Immuno-enhancement in lung cancer therapy via thalidomide and anti-PD-1 antibodies (Current Pharmaceutical Biotechnology, 2024).

CD47-specific ADCs for NSCLC treatment, demonstrating strong preclinical efficacy (Frontiers in Oncology, 2022).

Conclusion

Dr. Zu-Chian Chiang is a highly accomplished and promising researcher in the biomedical sciences, with a proven track record of impactful research, academic excellence, and leadership. His interdisciplinary expertise, from molecular synthesis to clinical trial collaboration, positions him as an outstanding candidate for any Best Researcher Award. With his continued contributions to science and society, Dr. Chiang exemplifies the qualities of innovation, dedication, and global impact.

Dr. Nipher Malika | Epidemiology | Best Researcher Award

Policy Researcher, at RAND, United States.

Dr. Nipher Malika is a dedicated public health researcher specializing in health disparities, minority health, HIV prevention, and social policy. She holds a Ph.D. in Social Policy & Social Research from Loma Linda University, along with a Master of Public Health in Research Epidemiology. As a researcher at the RAND Corporation, she conducts evidence-based studies on healthcare equity, social determinants of health, and culturally adapted interventions for marginalized communities, particularly African immigrants and Native American populations. Her work has been recognized with multiple awards, including the Research Excellence Award and The President’s Award, and she has served as a Health Disparities Fellow at leading institutions. Dr. Malika has published extensively in peer-reviewed journals such as PLOS Global Public Health and Journal of Racial and Ethnic Health Disparities, contributing to impactful policy research aimed at advancing global health equity and social justice.

Education 🎓

Dr. Nipher Malika holds a Ph.D. in Social Policy & Social Research (2021) from Loma Linda University, where she specialized in health disparities and epidemiological research. She also earned a Master of Public Health in Research Epidemiology (2015) and a Bachelor of Science in Biology (2011) from Northwest Nazarene University. Her educational background reflects a strong foundation in public health, data-driven research, and policy analysis.

Professional Experience 💼

Currently, Dr. Malika is a researcher at the RAND Corporation, a globally recognized think tank specializing in policy analysis, social research, and public health interventions. Her role involves conducting large-scale epidemiological studies, designing intervention strategies, and informing evidence-based policymaking. Her work has significant real-world implications, particularly for underserved communities and public health policy development.

Research Interests 🌍

Dr. Malika’s research centers on health disparities, minority health, HIV prevention, and social determinants of health. She has conducted extensive studies on African immigrant health, American Indian/Alaska Native populations, and global health equity, focusing on culturally adapted interventions, stigma reduction, and social policy impact. Her work aims to bridge healthcare gaps and promote evidence-based policies for marginalized communities.

Awards & Honors 🏆

Dr. Malika has received multiple prestigious awards for her research contributions, including the Research Excellence Award, The President’s Award, and the Hulda Crooks Award from Loma Linda University in 2021. Additionally, she was selected as a Health Disparities Research Fellow at the University of Michigan and the Colorado Department of Public Health & Environment, highlighting her dedication to advancing health equity.

Top Noted Publications 📚

1. Intersectional HIV Stigma in Sub-Saharan Africa, Latin America, and the Caribbean: Insights and Pathways Forward – A Scoping Review
Authors: Nipher M. Malika, Laura M. Bogart, Joseph K.B. Matovu, Lejeune Y. Lockett, David P. Lee, et al.
Journal: PLOS Global Public Health
Year: 2025
Citations: 0

2. Health Equity Checklist for Research
Authors: Nipher M. Malika, Stacie A. Salsbury, Ian Douglass Coulter, Kimberly Michelle Tippens, Michele J. Maiers, et al.
Journal: Ethics, Medicine and Public Health
Year: 2025
Citations: 0

Conclusion

Nipher Malika is highly competitive for the Best Researcher Award due to her strong academic background, significant research contributions, and policy-relevant expertise. Her work in health disparities, HIV prevention, and minority health aligns with pressing global health issues, making her research impactful.

To further strengthen her profile, she could aim for more independent research leadership, greater visibility in the academic community, and expansion into experimental studies. Given her track record, publication impact, and policy contributions, she is a strong candidate for this award.